© Copyright 2016 IP Research Consulting. All right reserved.
Home About Science & Technology Activomics Get involved Activomics-store Partners News Contact

About

Innovation

Innovation is the key word in our field. The Company’s R&D team is focused on proposing innovative therapeutic, diagnostic and biotechnological solutions.

Quality 

The medical biotechnology sector, of which Photeomix® is part is highly regulated.  Due to a number of different requirements Photeomix® has implemented its organisation in line with a quality system that is robust; and will allow the company to conform to the required regulations while at the same time retaining its flexibility in a very dynamic and competitive environment.

Accreditations

Photeomix® has received CIR (’Crédit d’Impôt Recherche’) accreditation extension for a five-year period (2015-2019) from the French Ministry of Higher Education and Research.   The French R&D tax credit initiative (CIR) gives eligible research-based French companies, who are subject to corporate tax in France, the ability to claim tax relief on costs generated in R&D activities outsourced to Photeomix®.

People

The strength of our company lies in the quality of our scientific team. PhD, MSc and BSc cooperate dynamically to allow exciting discoveries. Leadership Jane MacDougall Chief Executive Officer PhD, University of London More than 15 years post-doctoral research experience in medical sciences with Marketing, Sales and Customer Support experience from a series of different French biotech companies.   Iain Pemberton Founder, Executive Director of Research and Chief Financial Officer PhD, University of London One of the earliest researchers to investigate the HIV virus; has over 25 years’ experience in R&D plus extensive knowledge of the biotech industry, finance and market opportunities.
CV
CV
PDF
PDF
About
© Copyright 2016 IP Research Consulting. All right reserved.
Navigation Menu

About

Innovation 

Innovation is the key word in our field. The Company’s R&D team is focused on proposing innovative therapeutic, diagnostic and biotechnological solutions.

Quality 

The medical biotechnology sector, of which Photeomix® is part is highly regulated.  Due to a number of different requirements Photeomix® has implemented its organisation in line with a quality system that is robust; and will allow the company to conform to the required regulations while at the same time retaining its flexibility in a very dynamic and competitive environment.

Accreditations

Photeomix® has received CIR (’Crédit d’Impôt Recherche’) accreditation extension for a five-year period (2015-2019) from the French Ministry of Higher Education and Research.   The French R&D tax credit initiative (CIR) gives eligible research-based French companies, who are subject to corporate tax in France, the ability to claim tax relief on costs generated in R&D activities outsourced to Photeomix®.

People

The strength of our company lies in the quality of our scientific team. PhD, MSc and BSc cooperate dynamically to allow exciting discoveries. Leadership Jane MacDougall Chief Executive Officer PhD, University of London More than 15 years post-doctoral research experience in medical sciences with Marketing, Sales and Customer Support experience from a series of different French biotech companies.   Iain Pemberton Founder, Executive Director of Research and Chief Financial Officer PhD, University of London One of the earliest researchers to investigate the HIV virus; has over 25 years’ experience in R&D plus extensive knowledge of the biotech industry, finance and market opportunities.
PDF
PDF
CV
CV